Finasteride for Androgenetic Alopecia Is Not Associated With Sexual Dysfunction
TAKE-HOME MESSAGE
- This prospective study investigated the association between male sexual dysfunction and use of finasteride. No significant differences in male sexual dysfunction was observed between finasteride users (n=663) and non-user controls (n=99) using the Arizona Sexual Experience Survey (ASEX). A regression analysis showed that self-reported reduced libido and sexual performance, and not finasteride use, predicted a higher ASEX score.
- These findings, which reflect the data from other studies, suggest that sexual dysfunction associated with finasteride use in men with androgenetic alopecia may be less prevalent than is publicized.
– InYoung Kim, MD, PhD
BACKGROUND
The occurrence of sexual dysfunction side-effects associated with finasteride use in men with androgenetic alopecia (AGA) is thought to be less prevalent than is publicized. There is a need to investigate sexual dysfunction among finasteride users with population-based controls.
OBJECTIVE
To evaluate the presence of sexual dysfunction in men using finasteride or not using finasteride.
METHOD
Adult men visiting a dermatologist's office for any reason were asked to complete a survey including a modified version of the Arizona Sexual Experience Scale (ASEX) to assess the presence of sexual dysfunction with and without finasteride use.
RESULTS
Data from 762 men aged 18-82 were collected: 663 finasteride users and 99 non-finasteride users. There were no significant differences between finasteride users and non-user controls in reporting sexual dysfunction using the ASEX. Regression analysis indicated that self-reporting libido loss and reduced sexual performance, not finasteride use, predict a higher ASEX score.
CONCLUSION
The use of finasteride does not result in sexual dysfunction in men with AGA. These data are consistent with other large survey-based controlled studies.
Finasteride for Androgenetic Alopecia Is Not Associated With Sexual Dysfunction: A Survey-Based, Single-Centre, Controlled Study
J Eur Acad Dermatol Venereol 2019 Mar 05;[EPub Ahead of Print], RS Haber, AK Gupta, E Epstein, JL Carviel, KA FoleySkin Care Physicians of Costa Rica
Clinica Victoria en San Pedro: 4000-1054
Momentum Escazu: 2101-9574
Please excuse the shortness of this message, as it has been sent from
a mobile device.
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home